Literature DB >> 27109330

Risk Factors Associated With Neurogenic Bowel Complications and Dysfunction in Spinal Cord Injury.

Denise G Tate1, Martin Forchheimer2, Gianna Rodriguez2, Anthony Chiodo2, Anne Pelletier Cameron3, Michelle Meade2, Andrei Krassioukov4.   

Abstract

OBJECTIVES: To (1) assess the factors associated with methods of bowel management and bowel-related complications; and (2) determine the risk factors associated with bowel complications and overall bowel dysfunction, using multivariate modeling.
DESIGN: Cross-sectional observational study.
SETTING: A Spinal Cord Injury Model System, with additional participants recruited from other sites. PARTICIPANTS: Subjects (N=291) who incurred traumatic spinal cord injury (SCI) with resultant neurogenic bowel who were ≥5 years postinjury at the time of interview.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Constipation, bowel incontinence, and neurogenic bowel dysfunction questionnaire scores. These measures were all derived from the Bowel and Bladder Treatment Index. Data analyses included descriptive and bivariate statistics as well as logistic and linear regression modeling.
RESULTS: Risk factors contributing to bowel incontinence included overall bowel dysfunction as measured by the neurogenic bowel dysfunction score, timing of bowel program, being married or having a significant other, urinary incontinence, constipation, and use of diuretics. Constipation was best predicted by age, race/ethnicity, using laxatives/oral medications, incomplete tetraplegia, frequency of bowel movements, abdominal pain, access to clinicians and caregivers, and history of bowel surgeries. Neurogenic bowel dysfunction scores were predicted by neurologic classification; use of laxatives, oral medications, or both; bowel incontinence; and frequency of fiber intake.
CONCLUSIONS: These results suggest a number of factors that should be considered when treating neurogenic bowel complications and dysfunction in persons with SCI.
Copyright © 2016 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Constipation; Fecal incontinence; Neurogenic bowel; Rehabilitation; Risk factors; Spinal cord injuries

Mesh:

Year:  2016        PMID: 27109330     DOI: 10.1016/j.apmr.2016.03.019

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  16 in total

1.  Neurogenic Bowel Dysfunction in Patients with Neurogenic Bladder.

Authors:  Laura Martinez; Leila Neshatian; Rose Khavari
Journal:  Curr Bladder Dysfunct Rep       Date:  2016-10-20

Review 2.  Neurogenic bowel management for the adult spinal cord injury patient.

Authors:  John T Stoffel; F Van der Aa; D Wittmann; S Yande; S Elliott
Journal:  World J Urol       Date:  2018-06-27       Impact factor: 4.226

Review 3.  Recommendations for evaluation of neurogenic bladder and bowel dysfunction after spinal cord injury and/or disease.

Authors:  Denise G Tate; Tracey Wheeler; Giulia I Lane; Martin Forchheimer; Kim D Anderson; Fin Biering-Sorensen; Anne P Cameron; Bruno Gallo Santacruz; Lyn B Jakeman; Michael J Kennelly; Steve Kirshblum; Andrei Krassioukov; Klaus Krogh; M J Mulcahey; Vanessa K Noonan; Gianna M Rodriguez; Ann M Spungen; David Tulsky; Marcel W Post
Journal:  J Spinal Cord Med       Date:  2020-03       Impact factor: 1.985

4.  Reliability, validity and sensitivity to change of neurogenic bowel dysfunction score in patients with spinal cord injury.

Authors:  D Erdem; D Hava; P Keskinoğlu; Ç Bircan; Ö Peker; K Krogh; S Gülbahar
Journal:  Spinal Cord       Date:  2017-07-11       Impact factor: 2.772

5.  Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review.

Authors:  Ferdinando D'Amico; Steven D Wexner; Carolynne J Vaizey; Célia Gouynou; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2020-07-17       Impact factor: 4.623

6.  Dysbiosis of gut microbiota is associated with serum lipid profiles in male patients with chronic traumatic cervical spinal cord injury.

Authors:  Chao Zhang; Yingli Jing; Wenhao Zhang; Jie Zhang; Mingliang Yang; Liangjie Du; Yanmei Jia; Liang Chen; Huiming Gong; Jun Li; Feng Gao; Hongwei Liu; Chuan Qin; Changbin Liu; Yi Wang; Wenli Shi; Hongjun Zhou; Zhizhong Liu; Degang Yang; Jianjun Li
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

7.  Contextualizing the lived experience of quality of life for persons with spinal cord injury: A mixed-methods application of the response shift model.

Authors:  Edward J Rohn; Denise G Tate; Martin Forchheimer; Lisa DiPonio
Journal:  J Spinal Cord Med       Date:  2018-09-06       Impact factor: 1.985

Review 8.  The spinal cord-gut-immune axis as a master regulator of health and neurological function after spinal cord injury.

Authors:  Kristina A Kigerl; Kylie Zane; Kia Adams; Matthew B Sullivan; Phillip G Popovich
Journal:  Exp Neurol       Date:  2019-10-22       Impact factor: 5.330

9.  Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury Suggested citation: Jeffery Johns, Klaus Krogh, Gianna M. Rodriguez, Janice Eng, Emily Haller, Malorie Heinen, Rafferty Laredo, Walter Longo, Wilda Montero-Colon, Mark Korsten. Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Healthcare Providers. Journal of Spinal Cord Med. 2021. Doi:10.1080/10790268.2021.1883385.

Authors:  Jeffery Johns; Klaus Krogh; Gianna M Rodriguez; Janice Eng; Emily Haller; Malorie Heinen; Rafferty Laredo; Walter Longo; Wilda Montero-Colon; Mark Korsten
Journal:  J Spinal Cord Med       Date:  2021-05       Impact factor: 1.985

10.  Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers.

Authors:  Jeffery Johns; Klaus Krogh; Gianna M Rodriguez; Janice Eng; Emily Haller; Malorie Heinen; Rafferty Laredo; Walter Longo; Wilda Montero-Colon; Catherine Wilson; Mark Korsten
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.